RESUMEN
AIMS: Electrolytes and trace elements dysregulation play an important role in the progression of obesity and diabetes complications. The present study was designed to evaluate the insulin sensitizing effects of peroxisomes proliferators activated receptor gamma (PPAR-γ) agonist on trace elements in obesity induced type 2 diabetes mellitus and correlate with serum visfatin. MATERIALS AND METHODS: Wistar rats were categorized into five groups. Group I served as control; Group II fed on high fat diet (HFD); Group III fed on HFD and treated with rosiglitazone (3â¯mg/kg) for 7â¯days; Group IV were T2DM rats induce by HFD and low dose of streptozotocin (i.p. 35â¯mg/kg); Group V was T2DM rats treated with rosiglitazone (3â¯mg/kg) for 7â¯days. Serum and tissues electrolytes levels and renal, hepatic and cardiac tissues trace elements were estimated by flame photometer and atomic absorption spectroscopy. Serum visfatin was estimated by ELISA. Pearson correlations were analyzed among fasting blood glucose (FBG), serum visfatin and tissues trace elements. KEY FINDINGS: Results of the current study showed hyponatremia, hyperkalemia, hypomagnesemia and hypercalcemia in HFD and T2DM groups. HFD and T2DM also showed elevated copper and iron levels; however, zinc and selenium levels were decreased. Rosiglitazone treatment increased the insulin sensitization and altered these changes. A Strong association was observed among FBG, serum visfatin and trace elements levels of HFD and T2DM. SIGNIFICANCE: Obesity and diabetes mellitus disturbed visfatin, electrolytes and trace elements homeostasis. Rosiglitazone treatment restored these changes. The results of the study could serve as a basis for further studies for the prevention of diabetic complications.
Asunto(s)
Citocinas/sangre , Diabetes Mellitus Tipo 2/metabolismo , Dieta Alta en Grasa/efectos adversos , Nicotinamida Fosforribosiltransferasa/sangre , PPAR gamma/metabolismo , Oligoelementos/sangre , Animales , Glucemia/análisis , Diabetes Mellitus Experimental/tratamiento farmacológico , Diabetes Mellitus Experimental/metabolismo , Diabetes Mellitus Tipo 2/etiología , Hipoglucemiantes/farmacología , Resistencia a la Insulina , Masculino , Ratas , Ratas Wistar , Rosiglitazona , Espectrofotometría Atómica , Tiazolidinedionas/farmacologíaRESUMEN
The effects of radiation on neurons are incompletely characterized. We evaluated changes in the expression of neuronal nuclear and other proteins in the mouse hippocampus after 17-Gy whole-brain irradiation. Expression of neuronal nuclei (NeuN), neuron-specific enolas, prospero-related homeobox 1 (Prox1), calbindin D28k, and synaptophysin 1 in the CA1, CA3, and dentate gyrus of the hippocampus was determined by immunohistochemistry; neuronal numbers were estimated by design-based stereology. At 7 days after irradiation, there was a marked reduction of NeuN neurons in CA3. Stereologic estimates confirmed a significant reduction in NeuN neurons in CA3 at 7 days, in the dentate gyrus at 7 days, 3 weeks and 2 months, and in CA1 at 2 months compared with controls; neuron-specific enolase and prospero-related homeobox 1-positive neurons in the CA3 subregion were also decreased at 7 days. The numbers of granule and pyramidal cells identified by 4'6-diamidino-2-phenylindole nuclear staining, however, remained unchanged, and there were no changes in calbindin D28k or synaptophysin 1 immunoreactivity after irradiation. We conclude that irradiation may result in a temporary loss of neuronal protein expression in mouse hippocampus. These changes do not necessarily indicate loss of neurons and indicate the need for caution regarding the use of phenotypic markers such as NeuN to estimate changes in neuronal numbers after irradiation.
Asunto(s)
Hipocampo/fisiopatología , Hipocampo/efectos de la radiación , Proteínas del Tejido Nervioso/efectos de la radiación , Neuronas/efectos de la radiación , Traumatismos Experimentales por Radiación/fisiopatología , Radiación Ionizante , Animales , Biomarcadores/análisis , Biomarcadores/metabolismo , Calbindina 1 , Calbindinas , Recuento de Células , Muerte Celular/fisiología , Muerte Celular/efectos de la radiación , Proteínas de Unión al ADN , Modelos Animales de Enfermedad , Regulación hacia Abajo/fisiología , Regulación hacia Abajo/efectos de la radiación , Hipocampo/metabolismo , Proteínas de Homeodominio/metabolismo , Proteínas de Homeodominio/efectos de la radiación , Inmunohistoquímica , Masculino , Ratones , Ratones Endogámicos C57BL , Degeneración Nerviosa/etiología , Degeneración Nerviosa/metabolismo , Degeneración Nerviosa/fisiopatología , Proteínas del Tejido Nervioso/metabolismo , Neuronas/metabolismo , Neuronas/patología , Proteínas Nucleares/metabolismo , Proteínas Nucleares/efectos de la radiación , Fosfopiruvato Hidratasa/metabolismo , Fosfopiruvato Hidratasa/efectos de la radiación , Células Piramidales/metabolismo , Células Piramidales/patología , Células Piramidales/efectos de la radiación , Traumatismos Experimentales por Radiación/metabolismo , Proteína G de Unión al Calcio S100/metabolismo , Proteína G de Unión al Calcio S100/efectos de la radiación , Sinaptofisina/metabolismo , Sinaptofisina/efectos de la radiación , Proteínas Supresoras de Tumor/metabolismo , Proteínas Supresoras de Tumor/efectos de la radiaciónRESUMEN
The p75 neurotrophin receptor (p75(NTR)) is a death receptor which belongs to the tumor necrosis factor receptor super-family of membrane proteins. This study shows that p75(NTR) retarded cell cycle progression by induced accumulation of cells in G0/G1 and a reduction in the S phase of the cell cycle. The rescue of tumor cells from cell cycle progression by a death domain deleted (DeltaDD) dominant-negative antagonist of p75(NTR) showed that the death domain transduced anti-proliferative activity in a ligand-independent manner. Conversely, addition of NGF ligand rescued retardation of cell cycle progression with commensurate changes in components of the cyclin/cdk holoenzyme complex. In the absence of ligand, p75(NTR)-dependent cell cycle arrest facilitated an increase in apoptotic nuclear fragmentation of the prostate cancer cells. Apoptosis of p75(NTR) expressing cells occurred via the intrinsic mitochondrial pathway leading to a sequential caspase-9 and -7 cascade. Since the death domain deleted dominant-negative antagonist of p75(NTR) rescued intrinsic caspase associated apoptosis in PC-3 cells, this shows p75(NTR) was integral to ligand independent induction of apoptosis. Moreover, the ability of ligand to ameliorate the p75(NTR)-dependent intrinsic apoptotic cascade indicates that NGF functioned as a survival factor for p75(NTR) expressing prostate cancer cells.
Asunto(s)
Caspasas/fisiología , Ciclo Celular/efectos de los fármacos , Proteínas del Tejido Nervioso/fisiología , Neoplasias de la Próstata/fisiopatología , Receptores de Factor de Crecimiento Nervioso/fisiología , Apoptosis/efectos de los fármacos , Línea Celular Tumoral , Humanos , Etiquetado Corte-Fin in Situ , Masculino , Factor de Crecimiento Nervioso/farmacologíaRESUMEN
p75(NTR) was identified as a tumor and metastasis suppressor that functions in part via induction of apoptosis in tumor cells. To examine p75(NTR)-dependent apoptosis in tumor cells, we demonstrated that a dose-dependent increase in p75(NTR) expression was associated with a concomitant increase in the mitochondrial proapoptotic effector proteins Bad, Bax and Bik and a decrease in the mitochondrial prosurvival effector proteins phospho-Bad, Bcl-2 and Bcl-x(L). Significantly, p75(NTR)-dependent induction of cytochrome c release from the mitochondria occurred during CHX potentiation of apoptosis. Furthermore, p75(NTR) expression largely suppressed expression of IAP-1 and induced cleavage of procaspase-9 and procaspase-7 but not of procaspases 2, 3, 6, 8 and 10. A specific peptide inhibitor of procaspase-9 cleavage also inhibited cleavage of procaspase-7, indicating that caspase-7 is downstream of caspase-9. As end points of apoptosis, we observed p75(NTR)-dependent annexin V binding to the plasma membrane, an indicator of early apoptotic events, and Hoechst staining of DNA nuclear fragmentation, an indicator of late apoptotic events, whereas control tumor cells that lack expression of the p75(NTR) protein did not exhibit either of these apoptotic markers. Together, these results delineate the mitochondria-mediated apoptotic pathway of the p75(NTR) tumor-suppressor gene product.